STAT+: Pharmalittle: Novo faces patent challenge on Wegovy and Ozempic; Senate panel moves to address drug shortages

A U.S. Patent Office tribunal agreed to review the validity of a Novo Nordisk patent related to its blockbuster drugs Ozempic and Wegovy.
Click here to view original post